Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $417.82 million. The enterprise value is $226.67 million.

Market Cap	417.82M
Enterprise Value	226.67M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

NMRA has 161.95 million shares outstanding. The number of shares has increased by 2.49% in one year.

Current Share Class	161.95M
Shares Outstanding	161.95M
Shares Change (YoY)	+2.49%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	5.31%
Owned by Institutions (%)	35.33%
Float	84.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.28
P/TBV Ratio	2.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-57.14%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$2.15M
Employee Count	110
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NMRA has paid $130,000 in taxes.

Income Tax	130,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.41% in the last 52 weeks. The beta is 3.03, so NMRA's price volatility has been higher than the market average.

Beta (5Y)	3.03
52-Week Price Change	-80.41%
50-Day Moving Average	1.97
200-Day Moving Average	1.42
Relative Strength Index (RSI)	55.70
Average Volume (20 Days)	3,278,356

Short Selling Information

The latest short interest is 6.79 million, so 4.19% of the outstanding shares have been sold short.

Short Interest	6.79M
Short Previous Month	6.78M
Short % of Shares Out	4.19%
Short % of Float	8.07%
Short Ratio (days to cover)	12.48

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-240.60M
Pretax Income	-236.17M
Net Income	-236.30M
EBITDA	-240.38M
EBIT	-240.60M
Earnings Per Share (EPS)	-$1.47

Full Income Statement

Balance Sheet

The company has $217.59 million in cash and $19.96 million in debt, giving a net cash position of $197.63 million or $1.22 per share.

Cash & Cash Equivalents	217.59M
Total Debt	19.96M
Net Cash	197.63M
Net Cash Per Share	$1.22
Equity (Book Value)	182.88M
Book Value Per Share	1.13
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.49%
Shareholder Yield	-2.49%
Earnings Yield	-55.69%
FCF Yield	n/a

Analyst Forecast

The average price target for NMRA is $7.43, which is 187.98% higher than the current price. The consensus rating is "Buy".

Price Target	$7.43
Price Target Difference	187.98%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-37.77%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a